{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T19:38:48Z","timestamp":1692301128014},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.ejps.2005.05.006","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T16:27:57Z","timestamp":1119976077000},"page":"104-113","source":"Crossref","is-referenced-by-count":5,"title":["The pharmacokinetics of perindoprilat in normal volunteers and patients: Influence of age and disease state"],"prefix":"10.1016","volume":"26","author":[{"given":"Eva","family":"Parker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Aarons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillemette","family":"Resplandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2005.05.006_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0169-2607(93)90062-P","article-title":"The estimation of population pharmacokinetic parameters using an EM algorithm","volume":"41","author":"Aarons","year":"1993","journal-title":"Comput. Method Prog. Biomed."},{"key":"10.1016\/j.ejps.2005.05.006_bib2","first-page":"83","article-title":"Measurement of human enzyme level by direct radioimmunoassay","volume":"101","author":"Alhenc-Gelas","year":"1983","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ejps.2005.05.006_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2125.1990.tb03767.x","article-title":"The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment","volume":"30","author":"Begg","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib4","first-page":"325","article-title":"Specific and high affinity binding of perindoprilat, but not perindopril to blood ACE","volume":"30","author":"Bree","year":"1992","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.ejps.2005.05.006_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00315404","article-title":"The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects","volume":"39","author":"Brown","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1472-8206.1990.tb00486.x","article-title":"Pharmacokinetics of perindopril and its metabolites in healthy volunteers","volume":"4","author":"Devissaguet","year":"1990","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/jps.2600790817","article-title":"Radioimmunoassay of a new angiotensin-converting enzyme inhibitor (perindopril) in human plasma and urine: advantages of coupling anion-exchange column chromatography with radioimmunoassay","volume":"79","author":"Doucet","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2005.05.006_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00005344-198701000-00006","article-title":"Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model","volume":"9","author":"Francis","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib9","series-title":"Biopharmaceutics and Clinical Pharmacokinetics","author":"Gibaldi","year":"1984"},{"key":"10.1016\/j.ejps.2005.05.006_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3109\/00498259009046893","article-title":"Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor","volume":"20","author":"Grislain","year":"1990","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2005.05.006_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2125.1986.tb05205.x","article-title":"Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat","volume":"21","author":"Hockings","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2165\/00003495-200161060-00020","article-title":"Perindopril: an updated review of its use in hypertension","volume":"61","author":"Hurst","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2005.05.006_bib13","article-title":"Angiotensin converting enzyme inhibitors","volume":"vol. 11","author":"Johnston","year":"1988"},{"key":"10.1016\/j.ejps.2005.05.006_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/clpt.1990.45","article-title":"Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum","volume":"47","author":"Lecocq","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2005.05.006_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF00606623","article-title":"The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients","volume":"31","author":"Lees","year":"1987","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005344-198708000-00001","article-title":"Effects of intravenous S-9780, an angiotensin-converting enzyme inhibitor, in normotensive subjects","volume":"10","author":"Lees","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/clpt.1988.174","article-title":"Influence of age on the pharmacokinetics and pharmacodynamics of perindopril","volume":"44","author":"Lees","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2005.05.006_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01071348","article-title":"Pharmacokinetics of an ACE inhibitor, S-9780, in man: evidence of tissue binding","volume":"17","author":"Lees","year":"1989","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2005.05.006_bib19","series-title":"Applied Linear Statistical Models: Regression, Analysis of Variance and Experimental Designs","author":"Neter","year":"1974"},{"key":"10.1016\/j.ejps.2005.05.006_bib20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Riget","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2005.05.006_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2125.1992.tb04006.x","article-title":"The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure","volume":"33","author":"Sennesael","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib22","doi-asserted-by":"crossref","first-page":"283S","DOI":"10.1111\/j.1365-2125.1989.tb03493.x","article-title":"Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function","volume":"27","author":"Shionoiri","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2125.1989.tb05335.x","article-title":"Lisinopril population pharmacokinetics in elderly and renal disease patients with hypertension","volume":"27","author":"Thomson","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib24","first-page":"15","article-title":"The physiological disposition and metabolism of enalapril maleate in laboratory animals","volume":"19","author":"Tocco","year":"1982","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2005.05.006_bib25","first-page":"211","article-title":"The pharmacokinetics and pharmacodynamics of perindopril","volume":"26","author":"Tsai","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.1991.tb03880.x","article-title":"Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degree of renal insufficiency","volume":"32","author":"Verpooten","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2005.05.006_bib27","doi-asserted-by":"crossref","first-page":"181S","DOI":"10.1111\/j.1365-2125.1989.tb03480.x","article-title":"The pharmacokinetics and bioavailability of cilazapril in normal man","volume":"27","author":"Williams","year":"1989","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098705001727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098705001727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:22:41Z","timestamp":1548375761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098705001727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0928098705001727"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2005.05.006","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}